The research progress on synchronous endometrial and ovarian carcinoma
Frontiers in Oncology · 06.12.2023 · 13
DOI: 10.3389/fonc.2023.1291602 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 06.12.2023. Verfasst von Wenli Gan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West Chin…. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Synchronous endometrial and ovarian carcinoma (SEOC) is the most common combination of primary double cancer in the female reproductive system. The etiology and pathogenesis of SEOC remain unclear, and clinically, it is often misdiagnosed as metastatic cancer, affecting the formulation of treatment plans and prognosis for patients. This article provides a review of its epidemiology, pathological and clinical characteristics, risk factors, pathogenesis, diagnosis, treatment, and prognosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology and Obstetrics, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu, Sichuan, China.
- Department of Gynecology and Obstetrics, Affiliated Hospital of Sichuan Nursing Vocational College (The Third People's Hospital of Sichuan Province), Chengdu, Sichuan, China.
Zitieren
APA
Gan, W., & Bian, C. (2023). The research progress on synchronous endometrial and ovarian carcinoma. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1291602
Vancouver
Gan W, Bian C. The research progress on synchronous endometrial and ovarian carcinoma. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1291602
BibTeX
@article{Gan2023,
author = {Gan, Wenli and Bian, Ce},
title = {The research progress on synchronous endometrial and ovarian carcinoma},
journal = {Frontiers in Oncology},
year = {2023},
volume = {13},
doi = {10.3389/fonc.2023.1291602}
}
EUVIMED